RO.CH

272.2

-1.02%↓

NOVN.CH

96.71

-0.75%↓

LONN.CH

546.4

-0.07%↓

BANB.CH

62.85

+0.16%↑

RO.CH

272.2

-1.02%↓

NOVN.CH

96.71

-0.75%↓

LONN.CH

546.4

-0.07%↓

BANB.CH

62.85

+0.16%↑

RO.CH

272.2

-1.02%↓

NOVN.CH

96.71

-0.75%↓

LONN.CH

546.4

-0.07%↓

BANB.CH

62.85

+0.16%↑

RO.CH

272.2

-1.02%↓

NOVN.CH

96.71

-0.75%↓

LONN.CH

546.4

-0.07%↓

BANB.CH

62.85

+0.16%↑

RO.CH

272.2

-1.02%↓

NOVN.CH

96.71

-0.75%↓

LONN.CH

546.4

-0.07%↓

BANB.CH

62.85

+0.16%↑

Search

Straumann Holding AG

Gesloten

SectorGezondheidszorg

90.84 -0.04

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

90.12

Max

91.64

Belangrijke statistieken

By Trading Economics

Inkomsten

191M

Verkoop

1.2B

K/W

Sectorgemiddelde

35.561

35.664

EPS

1.66

Dividendrendement

1

Winstmarge

15.499

Werknemers

11,948

EBITDA

416M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+46.91% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.00%

3.12%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

15B

Vorige openingsprijs

90.88

Vorige sluitingsprijs

90.84

Nieuwssentiment

By Acuity

100%

0%

360 / 371 Rangschikking in Healthcare

Straumann Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Peer Vergelijking

Prijswijziging

Straumann Holding AG Prognose

Koersdoel

By TipRanks

46.91% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 133.22 CHF  46.91%

Hoogste 150 CHF

Laagste 113 CHF

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Straumann Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

6

Buy

3

Hold

1

Sell

Sentiment

By Acuity

360 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
help-icon Live chat